Company · CIK 0001587221 · SIC 2834 — Pharmaceutical Preparations
Zosano Pharma Corp · ZSAN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2018 SForm 4 → | Feb 28, 5:38 pm EST | Amzak Capital Management, LLC +210% Owner | 88,281 | $8.40 | $741,174 | 0 | −100% | plan? |
| Dec 6, 2017 PForm 4 → | Dec 8, 4:24 pm EST | Kenneth GreathouseDirector | 55,000 | $0.6074 | $33,407 | 200,000 | +37.9% | plan? |
| Nov 30, 2017 PForm 4 → | Dec 4, 4:05 pm EST | Kenneth GreathouseDirector | 95,000 | $0.6211 | $59,007 | 145,000 | +190% | plan? |
| Nov 14, 2017 PForm 4 → | Nov 16, 5:28 pm EST | Kenneth GreathouseDirector | 50,000 | $0.6232 | $31,159 | 50,000 | — | plan? |
| Aug 9, 2017 DForm 4 → | Aug 11, 7:18 pm EDT | John Peter WalkerPresident and CEO, Director | 26,666 | — | — | 180,228 | — | plan? |
| May 25, 2017 PForm 4 → | May 25, 8:55 pm EDT | Georgia ErbezCFO and Chief Business Officer | 68,000 | $1.32 | $89,760 | 115,750 | +142% | plan? |
| May 24, 2017 PForm 4/A → | May 26, 5:53 pm EDT | John Peter WalkerInterim CEO, Director | 73,716 | $1.36 | $99,891 | 206,894 | +55.4% | plan? |
| May 24, 2017 PForm 4 → | May 25, 8:45 pm EDT | John Peter WalkerInterim CEO, Director | 73,716 | $1.36 | $99,891 | 206,894 | +55.4% | plan? amended |
| May 18, 2017 AForm 4 → | May 22, 6:25 pm EDT | John Peter WalkerInterim CEO, Director | 60,000 | — | — | 133,178 | — | plan? |
| May 4, 2017 MForm 4 → | May 8, 6:13 pm EDT | John Peter WalkerDirector | 9,478 | — | — | 73,178 | — | plan? |
| Mar 20, 2017 MForm 4 → | Mar 22, 5:39 pm EDT | Konstantinos AlatarisPresident, CEO, Director | 127,389 | $1.45 | $184,714 | 254,778 | — | plan? |
| Feb 13, 2017 SForm 4 → | Feb 14, 5:37 pm EST | M James Barrett10% Owner | 1,099,996 | $2.01 | $2,211,432 | 952,809 | −53.6% | plan? |
| Feb 13, 2017 SForm 4 → | Feb 14, 5:36 pm EST | New Enterprise Associates 12, Limited Partnership +610% Owner | 1,099,996 | $2.01 | $2,211,432 | 952,809 | −53.6% | plan? |
| Sep 16, 2016 SForm 4 → | Sep 20, 4:39 pm EDT | M James Barrett10% Owner | 7,471 | $0.75 | $5,603 | 2,052,805 | −0.36% | plan? |
| Sep 16, 2016 SForm 4 → | Sep 20, 4:39 pm EDT | New Enterprise Associates 12, Limited Partnership +710% Owner | 7,471 | $0.75 | $5,603 | 2,052,805 | −0.36% | plan? |
| Sep 13, 2016 SForm 4 → | Sep 15, 4:31 pm EDT | M James Barrett10% Owner | 10,000 | $0.74 | $7,400 | 2,060,276 | −0.48% | plan? |
| Sep 13, 2016 SForm 4 → | Sep 15, 4:30 pm EDT | New Enterprise Associates 12, Limited Partnership +710% Owner | 10,000 | $0.74 | $7,400 | 2,060,276 | −0.48% | plan? |
| Aug 29, 2016 SForm 4 → | Aug 31, 4:36 pm EDT | M James Barrett10% Owner | 50,000 | $1.01 | $50,440 | 2,070,276 | −2.36% | plan? |
| Aug 29, 2016 SForm 4 → | Aug 31, 4:35 pm EDT | New Enterprise Associates 12, Limited Partnership +710% Owner | 50,000 | $1.01 | $50,440 | 2,070,276 | −2.36% | plan? |
| Aug 24, 2016 SForm 4 → | Aug 26, 5:08 pm EDT | M James Barrett10% Owner | 1,200 | $1.21 | $1,452 | 2,120,276 | −0.06% | plan? |
| Aug 24, 2016 SForm 4 → | Aug 26, 5:07 pm EDT | New Enterprise Associates 12, Limited Partnership +710% Owner | 1,200 | $1.21 | $1,452 | 2,120,276 | −0.06% | plan? |
| Aug 19, 2016 PForm 4 → | Aug 22, 7:46 pm EDT | Georgia ErbezInterim CFO | 47,750 | $1.32 | $63,030 | 47,750 | — | plan? |
| Aug 19, 2016 PForm 4 → | Aug 22, 7:29 pm EDT | Hayley LewisVP, Reg Affairs & Quality | 4,775 | $1.32 | $6,303 | 4,775 | — | plan? |
| Aug 19, 2016 PForm 4 → | Aug 22, 7:18 pm EDT | Donald J KellermanVP, Clinical Dev & Med Affairs | 15,920 | $1.32 | $21,014 | 15,920 | — | plan? |
| Aug 19, 2016 PForm 4 → | Aug 22, 7:05 pm EDT | John Peter WalkerDirector | 63,700 | $1.32 | $84,084 | 63,700 | — | plan? |
| Aug 19, 2016 PForm 4 → | Aug 22, 6:45 pm EDT | Konstantinos AlatarisPresident, CEO, Director | 127,389 | $1.32 | $168,153 | 127,389 | — | plan? |
| Aug 19, 2016 PForm 4 → | Aug 22, 5:11 pm EDT | Kleanthis G XanthopoulosDirector | 15,920 | $1.32 | $21,014 | 21,920 | +265% | plan? |
| Jul 19, 2016 SForm 4 → | Jul 21, 4:32 pm EDT | M James Barrett10% Owner | 23,681 | $1.27 | $30,132 | 2,121,476 | −1.10% | plan? |
| Jul 19, 2016 SForm 4 → | Jul 21, 4:31 pm EDT | New Enterprise Associates 12, Limited Partnership +710% Owner | 23,681 | $1.27 | $30,132 | 2,121,476 | −1.10% | plan? |
| Jul 13, 2016 SForm 4 → | Jul 15, 4:34 pm EDT | M James Barrett10% Owner | 13,382 | $1.20 | $16,060 | 2,145,157 | −0.62% | plan? |
| Jul 13, 2016 SForm 4 → | Jul 15, 4:33 pm EDT | New Enterprise Associates 12, Limited Partnership +710% Owner | 13,382 | $1.20 | $16,060 | 2,145,157 | −0.62% | plan? |
| Apr 1, 2015 AForm 4 → | Apr 2, 7:18 pm EDT | Troy Edward WilsonDirector | 3,000 | — | — | 3,000 | — | plan? |
| Apr 1, 2015 AForm 4 → | Apr 2, 7:17 pm EDT | Kleanthis G XanthopoulosDirector | 6,000 | — | — | 6,000 | — | plan? |
| Jan 30, 2015 PForm 4 → | Feb 2, 1:33 pm EST | M James BarrettDirector, 10% Owner | 23,457 | $11.00 | $258,027 | 2,158,539 | +1.10% | plan? |
| Jan 30, 2015 CForm 4 → | Feb 2, 1:33 pm EST | M James BarrettDirector, 10% Owner | 341,201 | $9.35 | $3,190,229 | 2,135,082 | — | plan? |
| Jan 30, 2015 PForm 4 → | Feb 2, 1:32 pm EST | New Enterprise Associates 12, Limited Partnership +810% Owner | 23,457 | $11.00 | $258,027 | 2,158,539 | +1.10% | plan? |
| Jan 30, 2015 CForm 4 → | Feb 2, 1:32 pm EST | New Enterprise Associates 12, Limited Partnership +810% Owner | 341,201 | $9.35 | $3,190,229 | 2,135,082 | — | plan? |
| Jan 30, 2015 PForm 4 → | Feb 2, 1:17 pm EST | BioMed Realty Trust Inc +110% Owner | 26,543 | $11.00 | $291,973 | 545,447 | +5.12% | plan? |
| Jan 30, 2015 CForm 4 → | Feb 2, 1:17 pm EST | BioMed Realty Trust Inc +110% Owner | 382,070 | $9.35 | $3,572,355 | 1,896,982 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2019 AForm 4 → | Feb 28, 4:15 pm EST | Gregory David KitchenerChief Financial Officer | 25,000 | — | — | 25,000 | — | |
| Jan 14, 2019 AForm 4 → | Jan 16, 7:19 pm EST | Linda S GraisDirector | 25,000 | — | — | 25,000 | — | |
| Oct 15, 2018 AForm 4 → | Oct 16, 4:54 pm EDT | Gregory David KitchenerChief Financial Officer | 100,000 | — | — | 100,000 | — | |
| May 31, 2018 AForm 4 → | Jun 1, 7:19 pm EDT | Kleanthis G XanthopoulosDirector | 25,000 | — | — | 25,000 | — | |
| May 31, 2018 AForm 4 → | Jun 1, 7:12 pm EDT | Troy Edward WilsonDirector | 25,000 | — | — | 25,000 | — | |
| May 31, 2018 AForm 4 → | Jun 1, 7:06 pm EDT | Joseph P HaganDirector | 25,000 | — | — | 25,000 | — | |
| May 31, 2018 AForm 4 → | Jun 1, 7:00 pm EDT | Kenneth GreathouseDirector | 25,000 | — | — | 25,000 | — | |
| May 31, 2018 AForm 4 → | Jun 1, 6:51 pm EDT | Hayley LewisSenior VP, Operations | 100,000 | — | — | 100,000 | — | |
| May 31, 2018 AForm 4 → | Jun 1, 6:40 pm EDT | Donald J KellermanVP, Clinical Dev & Med Affairs | 100,000 | — | — | 100,000 | — | |
| May 31, 2018 AForm 4 → | Jun 1, 6:32 pm EDT | John Peter WalkerPresident and CEO, Director | 400,000 | — | — | 100,000 | — | |
| May 17, 2018 AForm 4 → | May 21, 8:16 pm EDT | Steve ElmsDirector, 10% Owner | 25,000 | — | — | 25,000 | — | |
| Jan 2, 2018 AForm 4 → | Mar 2, 7:22 pm EST | Kenneth GreathouseDirector | 30,000 | — | — | 30,000 | — | late |
| Jan 2, 2018 AForm 4 → | Mar 2, 7:13 pm EST | Troy Edward WilsonDirector | 30,000 | — | — | 30,000 | — | late |
| Jan 2, 2018 AForm 4 → | Mar 2, 7:07 pm EST | Joseph P HaganDirector | 30,000 | — | — | 30,000 | — | late |
| Jan 2, 2018 AForm 4 → | Mar 2, 7:01 pm EST | Kleanthis G XanthopoulosDirector | 30,000 | — | — | 30,000 | — | late |
| Oct 3, 2017 AForm 4 → | Oct 5, 5:38 pm EDT | Kenneth GreathouseDirector | 60,000 | — | — | 60,000 | — | |
| Aug 9, 2017 AForm 4 → | Aug 11, 7:18 pm EDT | John Peter WalkerPresident and CEO, Director | 300,000 | — | — | 300,000 | — | |
| May 31, 2017 AForm 4 → | Apr 27, 2018, 6:18 pm EDT | Donald J KellermanVP, Clinical Dev & Med Affairs | 180,000 | — | — | 180,000 | — | late |
| May 31, 2017 AForm 4 → | Apr 27, 2018, 6:06 pm EDT | Hayley LewisSenior VP, Operations | 180,000 | — | — | 180,000 | — | late |
| May 4, 2017 MForm 4 → | May 8, 6:13 pm EDT | John Peter WalkerDirector | 9,478 | — | — | 0 | — | |
| Apr 10, 2017 AForm 4 → | Apr 12, 7:36 pm EDT | Donald J KellermanVP, Clinical Dev & Med Affairs | 15,000 | — | — | 15,000 | — | |
| Apr 10, 2017 AForm 4 → | Apr 12, 7:28 pm EDT | Hayley LewisVP, Reg Affairs & Quality | 15,000 | — | — | 15,000 | — | |
| Apr 10, 2017 AForm 4 → | Apr 12, 7:21 pm EDT | Winnie Wing-Kei TsoChief Financial Officer | 3,500 | — | — | 17,500 | — | |
| Mar 20, 2017 MForm 4 → | Mar 22, 5:39 pm EDT | Konstantinos AlatarisPresident, CEO, Director | 127,389 | — | — | 0 | — | |
| Nov 2, 2016 AForm 4 → | Nov 4, 5:42 pm EDT | Troy Edward WilsonDirector | 20,000 | — | — | 20,000 | — | |
| Nov 2, 2016 AForm 4 → | Nov 4, 5:37 pm EDT | Kleanthis G XanthopoulosDirector | 20,000 | — | — | 20,000 | — | |
| Nov 2, 2016 AForm 4 → | Nov 4, 5:20 pm EDT | John Peter WalkerDirector | 30,000 | — | — | 30,000 | — | |
| Nov 2, 2016 AForm 4 → | Nov 4, 5:18 pm EDT | Joseph P HaganDirector | 20,000 | — | — | 20,000 | — | |
| Sep 7, 2016 AForm 4 → | Sep 9, 4:29 pm EDT | Georgia ErbezCBO and Interim CFO | 252,000 | — | — | 252,000 | — | |
| Aug 19, 2016 PForm 4 → | Aug 22, 7:46 pm EDT | Georgia ErbezInterim CFO | 95,500 | $0.125 | $11,938 | 47,750 | — | |
| Aug 19, 2016 PForm 4 → | Aug 22, 7:29 pm EDT | Hayley LewisVP, Reg Affairs & Quality | 9,550 | $0.125 | $1,194 | 4,775 | — | |
| Aug 19, 2016 PForm 4 → | Aug 22, 7:18 pm EDT | Donald J KellermanVP, Clinical Dev & Med Affairs | 31,840 | $0.125 | $3,980 | 15,920 | — | |
| Aug 19, 2016 PForm 4 → | Aug 22, 7:05 pm EDT | John Peter WalkerDirector | 127,400 | $0.125 | $15,925 | 63,700 | — | |
| Aug 19, 2016 PForm 4 → | Aug 22, 6:45 pm EDT | Konstantinos AlatarisPresident, CEO, Director | 254,778 | $0.125 | $31,847 | 127,389 | — | |
| Aug 19, 2016 PForm 4 → | Aug 22, 5:11 pm EDT | Kleanthis G XanthopoulosDirector | 31,840 | $0.125 | $3,980 | 15,920 | — | |
| Jun 30, 2016 AForm 4 → | Jul 1, 5:05 pm EDT | Eric ScharinVP, Engineering & Operations | 3,750 | — | — | 3,750 | — | |
| Jun 30, 2016 AForm 4 → | Jul 1, 4:56 pm EDT | Winnie Wing-Kei TsoChief Financial Officer | 14,000 | — | — | 14,000 | — | |
| May 4, 2016 AForm 4 → | May 6, 9:39 pm EDT | John Peter WalkerDirector | 16,291 | — | — | 9,478 | — | |
| Mar 29, 2016 AForm 4 → | Mar 30, 4:14 pm EDT | Winnie Wing-Kei TsoChief Financial Officer | 15,000 | — | — | 15,000 | — | |
| Feb 3, 2016 AForm 4 → | Feb 4, 7:42 pm EST | Konstantinos AlatarisPresident, CEO, Director | 200,000 | — | — | 200,000 | — | |
| Dec 15, 2015 DForm 4/A → | Dec 17, 1:30 pm EST | Konstantinos AlatarisPresident | 209,394 | — | — | 0 | — | |
| Dec 15, 2015 ADForm 4 → | Dec 16, 6:18 pm EST | Laxmi PeriSr. Vice President, Operations | 80,000 | — | — | 40,000 | — | |
| Dec 15, 2015 ADForm 4 → | Dec 16, 6:15 pm EST | Konstantinos AlatarisPresident | 418,788 | — | — | 209,394 | — | amended |
| Sep 21, 2015 AForm 4 → | Oct 1, 4:58 pm EDT | Konstantinos AlatarisPresident | 209,394 | — | — | 209,394 | — | late |
| May 22, 2015 AForm 4 → | May 27, 11:15 am EDT | Laxmi PeriSr. Vice President, Operations | 40,000 | — | — | 40,000 | — | |
| May 22, 2015 AForm 4 → | May 27, 11:13 am EDT | Joseph P HaganDirector | 28,000 | — | — | 28,000 | — | |
| Jan 30, 2015 CForm 4 → | Feb 2, 1:33 pm EST | M James BarrettDirector, 10% Owner | — | — | — | — | — | |
| Jan 30, 2015 CForm 4 → | Feb 2, 1:32 pm EST | New Enterprise Associates 12, Limited Partnership +810% Owner | — | — | — | — | — | |
| Jan 30, 2015 CForm 4 → | Feb 2, 1:17 pm EST | BioMed Realty Trust Inc +110% Owner | 3,572,383 | — | — | 0 | — |